Education History
Postdoctoral Fellowship |
University of Utah School of Medicine |
Postdoctoral Fellow |
---|---|---|
University of Alberta |
Postdoctoral Fellow | |
Graduate Training |
University of Alberta |
PhD |
Maharaja Sayajirao University of Baroda |
MSc | |
Undergraduate |
Gujarat University |
BSc |
Selected Publications
Journal Article
- Azim A, Hu B, Gilligan S, Sarwal A, Hartsell S, Pandya V, Raphael KL (2023). How I Evaluate a High Anion Gap Metabolic Acidosis. Clin J Am Soc Nephrol, 19(4), 525-527. (Read full article)
- Pandya V, Nguyen Sorenson AHT, Jones E, Young BA, Pearson LN (2022). Spirited away: Can ethanol testing in add-on orders provide meaningful results? Clin Biochem, 115, 97-102. (Read full article)
- Pandya V, Wilker C, Johnson-Davis KL (2023). Longitudinal trends in meconium drug detection in 46 US states between the years 2015-2020. J Anal Toxicol, 47(6), 495-503. (Read full article)
- Pandya V, McMillin GA, Young BA (2022). Deceptively Simple: Can Urine Samples from CLIA-Waived Urine Drug Screen Devices Be Reused for Confirmatory Testing? J Appl Lab Med, 8(2), 341-346. (Read full article)
- Pandya V, Wilker C, McMillin GA (2021). Can Umbilical Cord and Meconium Results Be Directly Compared? Analytical Approach Matters. J Anal Toxicol, 47(1), 96-105. (Read full article)
- Githaka JM, Tripathi N, Kirschenman R, Patel N, Pandya V, Kramer DA, Montpetit R, Zhu LF, Sonenberg N, Fahlman RP, Danial NN, Underhill DA, Goping IS (2021). BAD regulates mammary gland morphogenesis by 4E-BP1-mediated control of localized translation in mouse and human models. Nat Commun, 12(1), 2939. (Read full article)
- Salla M, Pandya V, Bhullar KS, Kerek E, Wong YF, Losch R, Ou J, Aldawsari FS, Velazquez-Martinez C, Thiesen A, Dyck JRB, Hubbard BP, Baksh S (2020). Resveratrol and Resveratrol-Aspirin Hybrid Compounds as Potent Intestinal Anti-Inflammatory and Anti-Tumor Drugs. Molecules, 25(17). (Read full article)
- Pandya V, Githaka JM, Patel N, Veldhoen R, Hugh J, Damaraju S, McMullen T, Mackey J, Goping IS (2020). BIK drives an aggressive breast cancer phenotype through sublethal apoptosis and predicts poor prognosis of ER-positive breast cancer. Cell Death Dis, 11(6), 448. (Read full article)
- Salla M, Aguayo-Ortiz R, Danmaliki GI, Zare A, Said A, Moore J, Pandya V, Manaloor R, Fong S, Blankstein AR, Gibson SB, Garcia LR, Meier P, Bhullar KS, Hubbard BP, Fiteh Y, Vliagoftis H, Goping IS, Brocks D, Hwang P, Velzquez-Martnez CA, Baksh S (2018). Identification and Characterization of Novel Receptor-Interacting Serine/Threonine-Protein Kinase 2 Inhibitors Using Structural Similarity Analysis. J Pharmacol Exp Ther, 365(2), 354-367. (Read full article)
- Pandya V, Glubrecht D, Vos L, Hanson J, Damaraju S, Mackey J, Hugh J, Goping IS (2016). The pro-apoptotic paradox: the BH3-only protein Bcl-2 interacting killer (Bik) is prognostic for unfavorable outcomes in breast cancer. Oncotarget, 7(22), 33272-85. (Read full article)
Book Chapter
- Pandya V, Frank EL (2022). A Simple, Fast, and Reliable LC-MS/MS Method for the Measurement of Homovanillic Acid and Vanillylmandelic Acid in Urine Specimens. In Methods Mol Biol (2546, pp. 175-183). United States. (Read full article)
Commentary
- Pandya V (2022). Commentary on Unexpected Fentanyl Detection during a Liver Transplant Evaluation. Clin Chem, 69(3), 226-227. (Read full article)
Case Report
- Smith Z, Goyal P, Pandya V, Thakar CV, Gudsoorkar PS (2023). Hyperuricemia in a patient with Waldenström’s Macroglobulinemia: An innocent bystander? Journal of Onco-Nephrology, 7(2), 79-83.
- Pandya V, Hunsaker JJH, Laulu SL, Genzen JR, Frank EL, Johnson LM, Rudolf JW (2021). Excessively low cholesterol and triglyceride levels in an apparently healthy patient. Clin Biochem, 96, 78-81. (Read full article)
Letter
- Hunsaker JJH, Laulu SL, Zupan E, Patel D, Pandya V, Rudolf JW (2024). Detection of a High-Dose Hook Effect and Evaluation of Dilutions of Urine Myoglobin Specimens Using a Serum Myoglobin Assay. [Letter to the editor]. Ann Lab Med, 44(4), 367-370. (Read full article)